Suchergebnisse - "Angiogenesis Inhibitors"

PubPharm (31.042)

1

Intravitreal faricimab for neovascular age-related macular degeneration previously treated with traditional anti-VEGF compounds : a real-world prospective study

enthalten in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie | 2024

von Grimaldi, G. | Cancian, G. | Rizzato, A. | +5

2

Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central or Hemi-Retinal Vein Occlusion

enthalten in: American journal of ophthalmology | 2024

von Ip, M. | Scott, I. | VanVeldhuisen, P. | +3

3

Comparing reactivation and retreatment for three doses of bevacizumab in type 1 retinopathy of prematurity

enthalten in: Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus | 2024

von Chopra, J. | Haider, K. | Boente, C.

4

Treatment for retinopathy of prematurity in Sweden 2008-2021 : Reduced gestational age of treated infants and remaining differences in treatment type and recurrence rates between hospitals

enthalten in: Acta ophthalmologica | 2024

von Holmström, G. | Hellström, A. | Teär Fahnehjelm, K. | +7

5

Impact of COVID-19 restrictions on the treatment of neovascular age-related macular degeneration

enthalten in: Acta ophthalmologica | 2024

von Bagi Nordsten, C. | Rasmussen, B. | Li, X. | +2

6

Comparability of input parameters in the German Retina.net ROP registry and the EU-ROP registry - An exemplary comparison between 2011 and 2021

enthalten in: Acta ophthalmologica | 2024

von Winter, K. | Pfeil, J. | Engmann, H. | +19

7

Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration

enthalten in: Ophthalmology. Retina | 2024

von Izquierdo-Serra, J. | Martin-Pinardel, R. | Moll-Udina, A. | +123

8

The role of angiogenesis inhibitors associated with tyrosine kinase inhibitors in the first-line treatment for EGFR-mutated advanced lung cancer

enthalten in: Critical reviews in oncology/hematology | 2024

von Motta-Guerrero, R. | Recondo, G. | Cardona, A. | +4

9

2-Desaza-annomontine (C81) impedes angiogenesis through reduced VEGFR2 expression derived from inhibition of CDC2-like kinases

enthalten in: Angiogenesis | 2024

von Zech, T. | Wolf, A. | Hector, M. | +7

10

ID1high/activin Ahigh glioblastoma cells contribute to resistance to anti-angiogenesis therapy through malformed vasculature

enthalten in: Cell death & disease | 2024

von Choi, S. | Jang, J. | Kim, Y. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[3105]